Steven R Magnuson

USPTO Granted Patents = 44 (Patent Applications = 21)

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 25 (Patent Applications = 32)

Average Co-Inventor Count = 9.9

ph-index = 6

Forward Citations = 168(Granted Patents)

Location History:

Hamden, CT (US) (2002 - 2005)
Wallingford, CT (US) (2005 - 2014)
Dublin, CA (US) (2012 - 2018)
South San Francisco, CA (US) (2016 - 2022)

Company Filing History:

Constellation Pharmaceuticals, Inc.

patents

8 out of 71

Bayer Pharmaceuticals Corporation

F. Hoffmann-la Roche Ag

patents

6. 1 out of 2,198

Smithkline Beecham Corporation

patents

7. 1 out of 832,880

Other

patents

where one patent can have more than one assignee

Years Active: 2002-2022

Loading Chart...

Areas of Expertise:

Therapeutic Compounds

Aminoquinazoline Derivatives

Pyridopyrimidine Derivatives

Isoquinoline Derivatives

JAK Inhibitor Compounds

Pyrazolopyrimidine Compounds

Pyrrolotriazine Derivatives

Heteroarylaminopyrazole Derivatives

Anilinopyrazole Derivatives

Naphthyridine Derivatives

Beta-3 Adrenoreceptor Agonists

44 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11247989 - Therapeutic compounds and uses thereof (2022-02-15),

2. 11168070 - Therapeutic compounds and uses thereof (2021-11-09),

3. 10696655 - Therapeutic compounds and uses thereof (2020-06-30),

4. 10358437 - Therapeutic compounds and uses thereof (2019-07-23),

5. 10308614 - Therapeutic compounds and uses thereof (2019-06-04),

6. 10280149 - Therapeutic compounds and uses thereof (2019-05-07),

7. 10258603 - Therapeutic compounds and uses thereof (2019-04-16),

8. 10206931 - Therapeutic compounds and uses thereof (2019-02-19),

9. 10202378 - Therapeutic compounds and uses thereof (2019-02-12),

10. 10202354 - Therapeutic compounds and uses thereof (2019-02-12),

11. 10183009 - Therapeutic compounds and uses thereof (2019-01-22),

12. 10155764 - Therapeutic compounds and uses thereof (2018-12-18),

13. 10150767 - Therapeutic compounds and uses thereof (2018-12-11),

14. 9855269 - Aminoquinazoline and pyridopyrimidine derivatives (2018-01-02),

15. 9763922 - Therapeutic compounds and uses thereof (2017-09-19),

Title: The Inventor Steven R Magnuson: Pioneering Innovations in Dublin, CA

Introduction: Steven R Magnuson is a distinguished inventor based in Dublin, CA, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Steven R Magnuson holds several patents in the areas of renewable energy, artificial intelligence, and medical devices, showcasing his versatility and ingenuity in inventing cutting-edge solutions.

Career Highlights: With a career spanning over two decades, Steven R Magnuson has worked with renowned research institutions and leading tech companies, consistently pushing the boundaries of innovation and creating solutions that have a lasting impact on society.

Collaborations: Throughout his career, Steven R Magnuson has collaborated with top engineers, scientists, and researchers, fostering a culture of innovation and knowledge-sharing that has led to the development of revolutionary technologies.

Conclusion: Steven R Magnuson's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology in Dublin, CA and beyond.

This text is generated by artificial intelligence and may not be accurate.